Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 126,610 | 132,231 | 120,773 | 119,591 | 112,137 |
| Cost of Goods | 38,663 | 44,007 | 39,459 | 37,830 | 35,570 |
| Gross Profit | 87,947 | 88,224 | 81,314 | 81,761 | 76,567 |
| Operating Expenses | 76,627 | 68,225 | 72,362 | 68,786 | 62,290 |
| Operating Income | 11,983 | 20,006 | 9,411 | 13,805 | 14,847 |
| Other Income | 62 | 340 | 578 | 61 | 18,795 |
| Pre-tax Income | 12,045 | 20,346 | 9,989 | 13,866 | 33,642 |
| Income Tax | 4,474 | 764 | -62,625 | 2,426 | 9,401 |
| Net Income Continuous | 7,571 | 19,582 | 72,614 | 11,440 | 24,241 |
| Net Income | $7,571 | $19,582 | $72,614 | $11,440 | $24,241 |
| EPS Basic Total Ops | 0.14 | 0.36 | 1.36 | 0.21 | 0.46 |
| EPS Basic Continuous Ops | 0.14 | 0.36 | 1.36 | 0.21 | 0.46 |
| EPS Diluted Total Ops | 0.14 | 0.35 | 1.34 | 0.21 | 0.45 |
| EPS Diluted Continuous Ops | 0.14 | 0.35 | 1.34 | 0.21 | 0.45 |
| EBITDA(a) | $13,770 | $21,723 | $11,452 | $15,962 | $17,184 |